DOV KADMON to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications DOV KADMON has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.102
-
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer. Mol Ther. 2006 Apr; 13(4):716-28.
Score: 0.061
-
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene. World J Urol. 2000 Apr; 18(2):125-9.
Score: 0.041